©The Author(s) 2020.
World J Hepatol. Jun 27, 2020; 12(6): 298-311
Published online Jun 27, 2020. doi: 10.4254/wjh.v12.i6.298
Published online Jun 27, 2020. doi: 10.4254/wjh.v12.i6.298
Table 5 Validation cohort: Comparison of the various scores and LIV-4
| Score comparison | Validation cohort P value |
| MELD vs LIV-4 | < 0.75 |
| MELD-Na vs LIV-4 | < 0.47 |
| SOFA vs LIV-4 | < 0.94 |
| CLIF-SOFA vs LIV-4 | < 0.27 |
| RFH vs LIV-4 | < 0.001 |
| APACHE III vs LIV-4 | < 0.074 |
- Citation: Lindenmeyer CC, Flocco G, Sanghi V, Lopez R, Kim AJ, Niyazi F, Mehta NA, Kapoor A, Carey WD, Mireles-Cabodevila E, Romero-Marrero C. LIV-4: A novel model for predicting transplant-free survival in critically ill cirrhotics. World J Hepatol 2020; 12(6): 298-311
- URL: https://www.wjgnet.com/1948-5182/full/v12/i6/298.htm
- DOI: https://dx.doi.org/10.4254/wjh.v12.i6.298